Gb Sciences Stock EBITDA

GBLX Stock  USD 0.01  0  33.00%   
GB Sciences fundamentals help investors to digest information that contributes to GB Sciences' financial success or failures. It also enables traders to predict the movement of GBLX Pink Sheet. The fundamental analysis module provides a way to measure GB Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GB Sciences pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

GBLX EBITDA Analysis

GB Sciences' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current GB Sciences EBITDA

    
  398.73 K  
Most of GB Sciences' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GB Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, GB Sciences reported earnings before interest,tax, depreciation and amortization of 398.73 K. This is 99.95% lower than that of the Healthcare sector and 99.6% lower than that of the Biotechnology industry. The ebitda for all United States stocks is 99.99% higher than that of the company.

GBLX EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GB Sciences' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of GB Sciences could also be used in its relative valuation, which is a method of valuing GB Sciences by comparing valuation metrics of similar companies.
GB Sciences is currently under evaluation in ebitda category among related companies.

GBLX Fundamentals

About GB Sciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze GB Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GB Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GB Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada. Growblox Sciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out GB Sciences Piotroski F Score and GB Sciences Altman Z Score analysis.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for GBLX Pink Sheet analysis

When running GB Sciences' price analysis, check to measure GB Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GB Sciences is operating at the current time. Most of GB Sciences' value examination focuses on studying past and present price action to predict the probability of GB Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GB Sciences' price. Additionally, you may evaluate how the addition of GB Sciences to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Please note, there is a significant difference between GB Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if GB Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GB Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.